samedan logo
 
 
spacer
home > pmps > autumn 2019 > five ways ar is revolutionising the manufacturing industry
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Five Ways AR is Revolutionising the Manufacturing Industry





“Simply put, we believe augmented reality is going to change the way we use technology forever” Tim Cook, Apple CEO at the fourth quarter earnings call, 2017

Prior to 2016, augmented reality (AR) in manufacturing was merely a pipe dream. Now, the potential for AR is recognised in many industries, including pharmaceutical manufacturing. The technology allows workers wearing transparent AR glasses to see both the real world around them as well as virtual information projected on their glasses to help them get their job done. All of this is hands free and at the location where the work is needed. AR is poised to revolutionise the manufacturing plant floor.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Patrick Liddy is a qualified Electrical Engineer BEng, CEM, MIEI from University College Dublin, Ireland, and holds a diploma in Business from Dublin Institute of Technology, Ireland. He brought innovation to the electricity market by founding Activation Energy, an energy efficiency software platform working with large energy users, and, following an acquisition by Nasdaq listed EnerNOC in 2014, led the company to be the largest demand response company both in Ireland and the UK. When Patrick first encountered AR smart glasses, he was convinced the technology would change how industry gets work done. In 2017, he re-entered the entrepreneurial space, founding UtilityAR, an AR software developer that creates AR solutions for utilities, industry, and other organisations who manage large portfolios of physical assets. The company now boasts local and multinational clients in the data centre, pharma, and utility sectors.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Premier Research Deepens Support for Oncology Sponsors By Expanding Oncology Leadership Team

As the number of next-generation oncology therapies in the clinical trial pipeline surges, Premier Research today announced three new oncology leadership team hires to strengthen the company’s expertise in the fast-growing areas of cell and gene therapies and immuno-oncology.
More info >>

White Papers

Accelerating the Time from DNA to Material

Merck

Cell line development is a critical step in upstream process development for monoclonal antibodies (mAbs). Unfortunately, the search for the bestproducing clone can be labor- and resource-intensive and is often compared with looking for a needle in a haystack. Cells must first be engineered to produce the biologic of interest and the cell line generated from a high producing clone must deliver a sufficiently high titer to support clinical studies, and ultimately commercialization of the therapeutic.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement